Kimberly Bolin

Patent Agent

Dr. Kimberly Bolin focuses her practice on patent counseling, prosecution, and diligence for a wide variety of life science and chemistry clients. With a unique combination of technical knowledge and decades of practical experience creatively managing portfolios, Kimberly's insights on patent matters are unparalleled. She has deep experience in helping clients protect small molecule pharmaceuticals and large molecule conjugates, from composition of matter onwards, through creative life cycle management strategies.

Download full bio 


  • Oyster Point Pharma to Be Acquired by Viatris 

  • Myovant Sciences Acquired by Sumitovant Biopharma 

  • Vera Therapeutics – $86 Million Follow-On Offering 

  • Neurocrine Partners With Takeda to Address Psychiatric Disorders 

  • Vaxcyte - $288 Million IPO 


    Fencing – formerly ranked in top 16 nationally for Vet40 Women’s Foil; when able, trains with her son (2016 US National Champion Div 2/Div 3 Men’s Foil; fences for UNC Chapel Hill 2022) at Salle Santa Cruz.

    Supporter of Women’s Rowing, particularly the Cambridge University Boat Club


  • University of California, Santa Cruz
    Post-Doctoral Research Fellow, Petroleum Research Fund Fellowship

  • Oxford University
    D. Phil., Biophysics, Oxford Center for Molecular Sciences Research Fellow

  • Wellesley College
    BA, Chemistry
    cum laude, with honors, 1990

Admissions & Credentials

U.S. Patent and Trademark Office


  • Silicon Valley Intellectual Property Law Association

  • Sigma Xi

  • Association for Women in Science

  • US Fencing Association